Ablation of periostin inhibits post-infarction myocardial regeneration in neonatal mice mediated by the phosphatidylinositol 3 kinase/glycogen synthase kinase 3β/cyclin D1 signalling pathway
Open Access
- 14 February 2017
- journal article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 113 (6), 620-632
- https://doi.org/10.1093/cvr/cvx001
Abstract
To resolve the controversy as to whether periostin plays a role in myocardial regeneration after myocardial infarction (MI), we created a neonatal mouse model of MI to investigate the influence of periostin ablation on myocardial regeneration and clarify the underlying mechanisms. Neonatal periostin-knockout mice and their wildtype littermates were subjected to MI or sham surgery. In the wildtype mice after MI, fibrosis was detectable at 3 days and fibrotic tissue was completely replaced by regenerated myocardium at 21 days. In contrast, in the knockout mice, significant fibrosis in the infarcted area was present at even 3 weeks after MI. Levels of phosphorylated-histone 3 and aurora B in the myocardium, detected by immunofluorescence and western blotting, were significantly lower in knockout than in wildtype mice at 7 days after MI. Similarly, angiogenesis was decreased in the knockout mice after MI. Expression of both the endothelial marker CD-31 and α-smooth muscle actin was markedly lower in the knockout than in wildtype mice at 7 days after MI. The knockout MI group had elevated levels of glycogen synthase kinase (GSK) 3β and decreased phosphatidylinositol 3-kinase (PI3K), phosphorylated serine/threonine protein kinase B (p-Akt), and cyclin D1, compared with the wildtype MI group. Similar effects were observed in experiments using cultured cardiomyocytes from neonatal wildtype or periostin knockout mice. Administration of SB216763, a GSK3β inhibitor, to knockout neonatal mice decreased myocardial fibrosis and increased angiogenesis in the infarcted area after MI. Ablation of periostin suppresses post-infarction myocardial regeneration by inhibiting the PI3K/GSK3β/cyclin D1 signalling pathway, indicating that periostin is essential for myocardial regeneration.Keywords
This publication has 59 references indexed in Scilit:
- Deletion of Periostin Protects Against Atherosclerosis in Mice by Altering Inflammation and Extracellular Matrix RemodelingArteriosclerosis, Thrombosis, and Vascular Biology, 2016
- Cardiomyocyte proliferation in cardiac development and regeneration: a guide to methodologies and interpretationsAmerican Journal of Physiology-Heart and Circulatory Physiology, 2015
- In vivocardiac reprogramming using an optimal single polycistronic construct: Figure 1Cardiovascular Research, 2015
- MicroRNA-34a Plays a Key Role in Cardiac Repair and Regeneration Following Myocardial InfarctionCirculation Research, 2015
- Therapeutic angiogenesis in a murine model of limb ischemia by recombinant periostin and its fasciclin I domainBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Cardiac Fibroblast Glycogen Synthase Kinase-3β Regulates Ventricular Remodeling and Dysfunction in Ischemic HeartCirculation, 2014
- De novo formation of a distinct coronary vascular population in neonatal heartScience, 2014
- Macrophages are required for neonatal heart regenerationJCI Insight, 2014
- Stromal Cell Derived Factor-1α Promotes C-Kit+ Cardiac Stem/Progenitor Cell Quiescence Through Casein Kinase 1α and GSK3βThe International Journal of Cell Cloning, 2013
- Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repairNature Medicine, 2007